Marina Wolfson - 14 Apr 2025 Form 4/A - Amendment Insider Report for BiomX Inc. (PHGE)

Reporting relationship: Chief Financial Officer
Issuer ticker: PHGE
Reported as of: 14 Apr 2025
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 21 Apr 2025, 07:44:33 UTC
Original report date: 18 Apr 2025
Prior SEC filing: 15 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Marina Wolfson

Key filing fact

Marina Wolfson filed Form 4/A - Amendment for BiomX Inc. (PHGE) on 21 Apr 2025.

Key facts

This page summarizes Marina Wolfson's Form 4/A - Amendment filing for BiomX Inc. (PHGE).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 Apr 2025, 07:44.

Change

Previous filing in this sequence was filed on 15 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHGE transaction

Common Stock

Award

Transaction value: $0
Shares: +68,545
Change %
Price: $0.000000
Shares after: 68,545
Date: 14 Apr 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHGE transaction Derivative

Common Stock Options - right to Buy

Award

Transaction value: $0
Shares: +95,000
Change %
Price: $0.000000
Shares after: 95,000
Date: 14 Apr 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 95,000
Exercise price: $0.5380
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a grant of 68,545 Restricted Stock Units ("RSUs"). The RSUs are immediately vested and convert into the Issuer's shares of common stock on a one-for-one basis.

Footnote F2

The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years.

SEC remarks

This amendment is being filed solely to correct an administrative error in Table II, Column 5. The number of derivative securities acquired was inadvertently reported under (D) of Column 5 instead of (A). No other changes have been made to the originally filed Form 4.